Kaléo announces appointments and new government business unit

Valiant Organics to start production of OAP and Pharma Intermediates

Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23

Rossari Biotech Q1 FY23 revenue up 88%; Profit up 17%

Profit after Tax (PAT) was up 18% for Q1 FY23 to reach Rs. 28.7 crore whereas EBITDA was up 52% to reach Rs. 57.7 crore

Sun Pharma Chairman Israel Makov to retire on completion of term

He was appointed a Board member and the Chairman in 2012.

Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI

Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.

Merck opens microbiology application lab in Jigani, Bengaluru

Merck’s first microbiology application and training lab in India

Avet Pharmaceuticals appoints George Svokos as President &CEO

George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies

W.R. Grace to expand capacity at small-molecule API plant

The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing

Lonza to build large-scale fill & finish facility in Switzerland

The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026